Sports Med startup wins FDA clearance for new meniscus repair system

Arcuro Medical Website  Arcuro Medical Receives FDA Regulatory Clearance (press release)

MISGAV, Israel, June 18, 2018 /PRNewswire/ -- Arcuro Medical Ltd. ("Arcuro"), a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced today that it received regulatory clearance from the United States Food and Drug Administration (FDA) for its SuperBall™ meniscus repair system. Meniscus tears are a common occurrence in many population groups: professional athletes, people who engage in daily sport activities, the ageing population, and people predisposed to ca...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top